Astronomers Astonished by Largest Explosion Since the Big Bang
You've heard of how mighty supernovas are, or of the ungodly amounts of energy released by gamma ray bursts.
But astronomers have just discovered a type of cosmic blast that puts all those to shame. They're called "extreme nuclear transients" (ENTs) — and they're quite literally the most powerful explosion witnessed since the dawn of time.
What produces ENTs is appropriately catastrophic: a star, at least three times as massive as our Sun, being obliterated by a supermassive black hole.
"We've observed stars getting ripped apart as tidal disruption events for over a decade, but these ENTs are different beasts, reaching brightnesses nearly ten times greater than what we typically see," Jason Hinkle, lead author of a new study published in the journal Science Advances, and a researcher at the University of Hawai'i's Institute for Astronomy (IfA), said in a statement about the work.
"Not only are ENTs far brighter than normal tidal disruption events, but they remain luminous for years, far surpassing the energy output of even the brightest known supernova explosions," Hinkle added.
The first clues emerged when Hinkle and his team were trawling through public data collected by the European Space Agency's Gaia mission, a vast three-dimensional map of over two billion stars and counting. Amid this stellar sea, they noticed flares of light, including one recorded in 2016 and another in 2018, that inexplicably lasted for several years. Most cosmic explosions, for comparison, only shine for several weeks.
"When I saw these smooth, long-lived flares from the centers of distant galaxies, I knew we were looking at something unusual," Hinkle said.
He wasn't the only one on the scent. Back in 2023, another team of astronomers reported a similar detection with the Zwicky Transient Facility in California. Following-up on these findings, Hinkle conducted additional observations with other telescopes, including the Keck Observatory in Hawaii, and linked these phenomena together.
The most formidable ENT, assigned the screenname-esque moniker of Gaia18cdj, unleashed 25 times more energy than the most powerful supernova ever detected. In one year, it radiated energy equal to all the energy our Sun will produce in its entire lifetime across billions of years — times one hundred. Typically, a supernova produces "just" one Sun's worth of energy.
To produce such a tremendous blast, a star has to undergo a brutal, slow death. That's what sets these apart from when a star falls into a black hole in a typical tidal disruption event, which culminates in a powerful but brief flash. An ENT draws out the torture, forming a disk of the star's shredded entrails that glows for years.
This aspect of a supermassive black hole's diet could tell us a lot about how they grew to their monstrous masses — a mystery that has long haunted astronomers — and how they stamped their name on a crucial period of the universe's history.
"By observing these prolonged flares, we gain insights into black hole growth when the universe was half its current age and galaxies were busy places — forming stars and feeding their supermassive black holes ten times more vigorously than they do today," said coauthor Benjamin Shappee, an associate professor at IfA, in a statement.
"These ENTs don't just mark the dramatic end of a massive star's life. They illuminate the processes responsible for growing the largest black holes in the universe," Hinkle added.
More on astronomy: Scientists Spot Mysterious Object in Our Galaxy Pulsing Every 44 Minutes
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Coherus BioSciences, Inc. (CHRS): A Bull Case Theory
We came across a bullish thesis on Coherus BioSciences, Inc. (CHRS) on Steve Wagner's Substack. In this article, we will summarize the bulls' thesis on CHRS. Coherus BioSciences, Inc. (CHRS)'s share was trading at $0.77 as of 30th May. CHRS's trailing P/E was 1.77 according to Yahoo Finance. Scientist in a lab working on a research project, focusing on biotechnology and healthcare advancements. Coherus BioSciences (CHRS), long overlooked by Wall Street, is taking a bold step into innovative oncology by partnering with UK-based STORM Therapeutics to test a novel cancer treatment strategy. The collaboration brings together Coherus's immunotherapy toripalimab (LOQTORZI) and STORM's first-in-class RNA-modifying enzyme inhibitor STC-15 in a Phase 1b/2 clinical trial. This unexpected pairing represents a fresh approach to immuno-oncology, targeting cancer through dual mechanisms that could produce synergistic effects. Toripalimab, already approved in the U.S. for nasopharyngeal carcinoma and under review for broader indications, offers proven checkpoint inhibition, while STC-15 introduces a cutting-edge method of disrupting RNA methylation processes linked to tumor growth and immune evasion. If this combo demonstrates efficacy, it could represent a completely new class of cancer therapy and place Coherus at the forefront of next-generation immuno-oncology innovation. Importantly, this partnership shows strategic vision from CHRS's management as they seek to differentiate the company beyond biosimilars and move deeper into proprietary immunotherapy. With the trial still in early stages and little market attention so far, the risk/reward profile for investors is potentially skewed to the upside. Should the data prove positive, the impact could be significant for both companies, especially for CHRS as it repositions itself as a serious player in oncology innovation. This under-the-radar development deserves close monitoring, as it could catalyze a major reevaluation of Coherus's valuation and growth trajectory. Previously, we have covered CHRS in March 2025 wherein we summarized a by the same author. Coherus BioSciences (CHRS) posted a strong turnaround in 2024 with $267M in revenue and $28.5M net income, driven by Loqtorzi's growth and the planned $250M Udenyca divestiture. The company pivoted fully to oncology, trimmed costs, and advanced its pipeline, yet management expressed frustration over the stock's undervaluation, hinting at potential M&A. Since our last coverage, the stock is down 38% as of 30th May. We don't trust CHRS' management as the stock lost more than 95% of its value in recent years and is still losing a ton of money. The market agrees with us and thinks this stock is going to go bankrupt. We believe CHRS should stop wasting shareholder's money, sell valuable assets, and liquidate the company. We don't think that's a likely outcome. Coherus BioSciences, Inc. (CHRS) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 10 hedge fund portfolios held CHRS at the end of the first quarter which was 10 in the previous quarter. While we acknowledge the potential of CHRS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Geek Girl Authority
an hour ago
- Geek Girl Authority
STAR TREK: STRANGE NEW WORLDS Season 3 Trailer Promises Romance, Action and Exploration
Paramount has unveiled the official trailer for Star Trek: Strange New Worlds Season 3, which you can watch below. Star Trek: Strange New Worlds The new trailer features the main cast, guest stars and Cillian O'Sullivan as legacy character Roger Korby. Expect the 10-episode new season to debut this summer. As the release date for Star Trek: Strange New Worlds Season 3 creeps ever closer, Paramount+ has released a full trailer. This trailer features a ton of tantalizing clips, including guest stars and sci-fi action and adventure. Scroll down to the bottom of the article to see it for yourself. Photo Credit: Marni Grossman/Paramount+ Star Trek: Strange New Worlds Season 3 Trailer The trailer features plenty of footage of the main cast. This includes Christopher Pike (Anson Mount), Una Chin-Riley (Rebecca Romijn) and Spock (Ethan Peck). Also featured are Nyota Uhura (Celia Rose Gooding), La'an Noonien-Singh (Christina Chong) and Erica Ortegas (Melissa Navia). We get to see both engineers, Pelia (Carol Kane) and Montgomery 'Scotty' Scott (Martin Quinn). Representing medical are M'Benga (Babs Olusanmokun) and Christine Chapel (Jess Bush). RELATED: Star Trek: Strange New Worlds Season 3 Releases Episode Titles and More Posters There are also plentiful glimpses of some beloved returning guest stars. These are James T. Kirk (Paul Wesley), Sam Kirk (Dan Jeannotte), Jenna Mitchell (Rong Fu) and Marie Batel (Melanie Scrofano). But we also get to see some new guest stars, too. These include Ortegas' little brother Beto (Mynor Luken). And we get to see legacy character Roger Korby (Cillian O'Sullivan). Finally, we get a tasty clip of Doug the Vulcan (Patton Oswalt) interacting with Spock. And of course, in addition to the impressively-sized ensemble cast and the exciting guest stars, the trailer also promises some strange new sci-fi adventures. The trailer includes more Klingon action, a glimpse of something that might be undead and Kirk taking the U.S.S. Enterprise 's center seat for the very first time. And there's also some lighthearted action, including sharing wine, at least one party and — dare I type it — even some hijinks? RELATED: Star Trek: Strange New Worlds Season 3 Gets Release Date (and New Poster) Two episodes of Strange New Worlds Season 3 will debut for streaming on Paramount+ on Thursday, July 17, 2025. But before that, the season is set to premiere at the Tribeca Festival 2025 in just one week, on Saturday, June 14, 2025. Will you be checking out the new episodes when they beam in? Catch up with Star Trek: Strange New Worlds Seasons 1 and 2, currently available for streaming on Paramount+. STAR TREK: STRANGE NEW WORLDS Season 3 Will Debut at Tribeca Festival 2025 Avery Kaplan is the author of several books and the Features Editor at Comics Beat. She was honored to serve as a judge for the 2021 Cartoonist Studio Prize Award and the 2021 Prism Awards. She lives in the mountains of Southern California with her partner and a pile of cats, and her favorite place to visit is the cemetery. You can also find her writing on Comics Bookcase, NeoText, Shelfdust, the Mary Sue, in many issues of PanelxPanel, and in the margins of the books in her personal library.
Yahoo
2 hours ago
- Yahoo
Incredible behaviour of tiny creatures filmed in world-first: 'Beauty overrides the disgust'
In a world-first, tiny worms have been filmed building towers so they can latch onto passing insects. The strategy has been developed to avoid fierce competition when food runs out, allowing them to travel large distances and find new locations to plunder. Although most people have never heard of nematode worms, they've probably accidentally eaten one. As a group, they are the most abundant creatures on Earth, and the species at the centre of the study are just 1mm-long and prey on bacteria that grows on rotting apples and pears. The research was conducted by the Max Planck Institute of Animal Behaviour, which dubbed the behaviour a 'rare example of collective hitchhiking in nature' because only slime moulds, fire ants, and spider mites had been known to operate like this. The worms slither over each other, spiralling their bodies to form a living tower which can sense touch as insects brush by, causing them to detach. The study's group leader, Dr Serena Ding spoke to Yahoo News Australia from her lab in Germany this week, explaining that without their insect hosts, the worms would struggle to travel large distances because their moist bodies would dry out and they'd die. Ding finds the nematodes 'beautiful', although she's well aware that others find them gross. 'I can understand that reaction as well, I've had that reaction to other kinds of worms,' she said. Related: 🦟 'Unimaginable' theory emerges about desolate continent Others have also clearly seen the beauty in the translucent nematode species she's studying – its name C. elegans relates to its 'elegant movement'. 'To me, they're not the disgusting type. When they come together to give you beautiful patterns, and fascinating behaviour to look at the beauty side overrides the disgust,' she said. 📸 Tourists to see 'extinct' animals behind national park's 25km predator-free fence 🚨 281 experts call for ban of 'toxic' product sold at Coles, Bunnings, Woolworths, Mitre 10 😳 Beach find highlights dark side of Queensland's $88 million tourism pledge It had long been known that nematodes created towers, but this is the first time the behaviour had been studied in detail. The Max Planck team first observed the worms forming themselves into a superorganism in an orchard and then waving in unison, trying to find a passing fruit fly. 'For so long natural worm towers existed only in our imaginations. But with the right equipment and lots of curiosity, we found them hiding in plain sight,' Ding said ahead of the paper's release. Postdoctoral Researcher Daniela Perez then collected nematodes to film them in her lab. Within two hours of placing them in a food-free environment they began to form towers, which were capable of standing for 12 hours. During this time they would form exploratory arms and bridges to reach new spaces. 'A nematode tower is not just a pile of worms. It's a coordinated structure, a superorganism in motion,' Perez said. 'The towers are actively sensing and growing. When we touched them, they responded immediately, growing toward the stimulus and attaching to it,' she added. Love Australia's weird and wonderful environment? 🐊🦘😳 Get our new newsletter showcasing the week's best stories.